JPS5070369A - - Google Patents

Info

Publication number
JPS5070369A
JPS5070369A JP49090864A JP9086474A JPS5070369A JP S5070369 A JPS5070369 A JP S5070369A JP 49090864 A JP49090864 A JP 49090864A JP 9086474 A JP9086474 A JP 9086474A JP S5070369 A JPS5070369 A JP S5070369A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP49090864A
Other versions
JPS5521749B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2773673A external-priority patent/IT1044236B/it
Priority claimed from IT2481174A external-priority patent/IT1051359B/it
Application filed filed Critical
Publication of JPS5070369A publication Critical patent/JPS5070369A/ja
Publication of JPS5521749B2 publication Critical patent/JPS5521749B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP9086474A 1973-08-09 1974-08-09 Expired JPS5521749B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2773673A IT1044236B (it) 1973-08-09 1973-08-09 Eteri di benzodiossoli 2.2 disostituiti
IT2481174A IT1051359B (it) 1974-07-04 1974-07-04 Eteri di benzodiossoli 2.2 diso stituiti

Publications (2)

Publication Number Publication Date
JPS5070369A true JPS5070369A (ja) 1975-06-11
JPS5521749B2 JPS5521749B2 (ja) 1980-06-12

Family

ID=26328539

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9086474A Expired JPS5521749B2 (ja) 1973-08-09 1974-08-09

Country Status (8)

Country Link
US (1) US3970672A (ja)
JP (1) JPS5521749B2 (ja)
BE (1) BE818710A (ja)
CA (1) CA1025448A (ja)
DE (1) DE2436721C3 (ja)
FR (1) FR2240004B1 (ja)
GB (1) GB1458321A (ja)
NL (1) NL158075B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031056A1 (en) * 1997-12-12 1999-06-24 Toyama Chemical Co., Ltd. Alkyl ether derivatives or salts thereof and calcium antagonists containing the same
JPH11263773A (ja) * 1997-12-12 1999-09-28 Toyama Chem Co Ltd アルキルエーテル誘導体またはその塩並びにそれらを含有するカルシウム拮抗剤

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4091222A (en) * 1973-08-09 1978-05-23 Elso Manghisi 2,2 Disubstituted-benzodioxoles
US4076833A (en) * 1973-12-17 1978-02-28 A. Christiaens Societe Anonyme Derivatives of 1,3-benzodioxole, the preparation and use thereof
FR2353291A1 (fr) * 1976-05-31 1977-12-30 Parcor Nouveaux derives du benzofuranne

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA749380A (en) * 1966-12-27 Smith Kline And French Laboratories Limited 1:3-benzodioxole derivatives
US2683742A (en) * 1951-02-23 1954-07-13 Searle & Co Nu, nu-disubstituted omega-arylmethoxy-omega-arylalkylamine derivatives
GB1220056A (en) * 1967-02-21 1971-01-20 Fisons Pest Control Ltd Substituted benzodioxoles
US3787443A (en) * 1971-02-25 1974-01-22 Zoecon Corp Aryloxy epithio ethers
US3915969A (en) * 1972-04-11 1975-10-28 Luso Farmaco Inst 2,2-Disubstituted benzodioxoles

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031056A1 (en) * 1997-12-12 1999-06-24 Toyama Chemical Co., Ltd. Alkyl ether derivatives or salts thereof and calcium antagonists containing the same
JPH11263773A (ja) * 1997-12-12 1999-09-28 Toyama Chem Co Ltd アルキルエーテル誘導体またはその塩並びにそれらを含有するカルシウム拮抗剤

Also Published As

Publication number Publication date
GB1458321A (en) 1976-12-15
CA1025448A (en) 1978-01-31
DE2436721C3 (de) 1978-09-21
FR2240004A1 (ja) 1975-03-07
NL7410708A (nl) 1975-02-11
BE818710A (fr) 1974-12-02
FR2240004B1 (ja) 1978-07-28
JPS5521749B2 (ja) 1980-06-12
DE2436721B2 (de) 1978-01-12
DE2436721A1 (de) 1975-04-17
US3970672A (en) 1976-07-20
AU7206674A (en) 1976-02-12
NL158075B (nl) 1978-10-16

Similar Documents

Publication Publication Date Title
AR201758A1 (ja)
AU476761B2 (ja)
AU465372B2 (ja)
AR201235Q (ja)
AR201231Q (ja)
AU465434B2 (ja)
AU450229B2 (ja)
FR2217001A2 (ja)
AR201229Q (ja)
FR2240004B1 (ja)
AR199451A1 (ja)
AU7575074A (ja)
AR210729A1 (ja)
AR200256A1 (ja)
AR196382A1 (ja)
AR197627A1 (ja)
AR201432A1 (ja)
AR195948A1 (ja)
AR193950A1 (ja)
AR195311A1 (ja)
AR200885A1 (ja)
AU447540B2 (ja)
AU461342B2 (ja)
AR196212Q (ja)
AU1891376A (ja)